Johnson & Johnson Amortization of Intangible Assets
Johnson & Johnson (JNJ) reported Amortization of Intangible Assets of $1.20 billion for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-07-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-07-23
- Johnson & Johnson amortization of intangible assets for the quarter ending 2026-06-28 was $1.20B, a 7.69% decline year-over-year.
- Johnson & Johnson amortization of intangible assets for the quarter ending 2026-03-29 was $1.20B, a 9.09% increase year-over-year.
- Johnson & Johnson amortization of intangible assets for the quarter ending 2025-12-28 was $1.20B, a 9.09% increase year-over-year.
- Johnson & Johnson amortization of intangible assets for the quarter ending 2025-09-28 was $1.00B, a 16.67% decline year-over-year.
- Johnson & Johnson amortization of intangible assets for fiscal 2025 was $4.60B, a 2.22% increase from fiscal 2024.
- Johnson & Johnson amortization of intangible assets for fiscal 2024 was $4.50B, a 0.00% change from fiscal 2023.
- Johnson & Johnson amortization of intangible assets for fiscal 2023 was $4.50B, a 15.38% increase from fiscal 2023.
- Johnson & Johnson amortization of intangible assets for fiscal 2023 was $3.90B, a 7.14% decline from fiscal 2022.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | $1.20B 10-Q · filed 2026-07-23 | $2.50B 10-Q · filed 2026-07-23 | $3.60B derived: sum of 3 quarters · filed 2026-07-23 | $4.60B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2026-03-29 | $1.20B 10-Q · filed 2026-04-22 | $2.40B derived: sum of 2 quarters · filed 2026-04-22 | $3.40B derived: sum of 3 quarters · filed 2026-04-22 | $4.70B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-12-28 | $1.20B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $2.20B derived: sum of 2 quarters · filed 2026-02-11 | $3.50B derived: sum of 3 quarters · filed 2026-07-23 | $4.60B 10-K · filed 2026-02-11 | ||||
| 2025-09-28 | $1.00B 10-Q · filed 2025-10-22 | $2.30B derived: sum of 2 quarters · filed 2026-07-23 | $3.40B 10-Q · filed 2025-10-22 | $4.50B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-06-29 | $1.30B 10-Q · filed 2026-07-23 | $2.40B 10-Q · filed 2026-07-23 | $3.50B derived: sum of 3 quarters · filed 2026-07-23 | $4.70B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-03-30 | $1.10B 10-Q · filed 2026-04-22 | $2.20B derived: sum of 2 quarters · filed 2026-04-22 | $3.40B derived: sum of 3 quarters · filed 2026-04-22 | $4.50B derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2024-12-29 | $1.10B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $2.30B derived: sum of 2 quarters · filed 2026-02-11 | $3.40B derived: sum of 3 quarters · filed 2026-02-11 | $4.50B 10-K · filed 2026-02-11 | ||||
| 2024-09-29 | $1.20B 10-Q · filed 2025-10-22 | $2.30B derived: sum of 2 quarters · filed 2025-10-22 | $3.40B 10-Q · filed 2025-10-22 | $4.50B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-06-30 | $1.10B 10-Q · filed 2025-07-24 | $2.20B 10-Q · filed 2025-07-24 | $3.30B derived: sum of 3 quarters · filed 2026-02-11 | $4.40B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-03-31 | $1.10B 10-Q · filed 2025-04-23 | $2.20B derived: sum of 2 quarters · filed 2026-02-11 | $3.30B derived: sum of 3 quarters · filed 2026-02-11 | $4.40B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2023-12-31 | $1.10B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $2.20B derived: sum of 2 quarters · filed 2026-02-11 | $3.30B derived: sum of 3 quarters · filed 2026-02-11 | $4.50B 10-K · filed 2026-02-11 | ||||
| 2023-10-01 | $1.10B 10-Q · filed 2024-10-23 | $2.20B derived: sum of 2 quarters · filed 2024-10-23 | $3.40B 10-Q · filed 2024-10-23 | $4.20B derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-07-02 | $1.10B 10-Q · filed 2024-07-25 | $1.20B 10-Q · filed 2023-07-31 | $2.20B 10-Q · filed 2024-07-25 | $2.40B 10-Q · filed 2023-07-31 | $3.10B derived: sum of 3 quarters · filed 2025-02-13 | $4.10B derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-04-02 | $1.10B 10-Q · filed 2024-05-01 | $1.20B 10-Q · filed 2023-04-28 | $2.00B derived: sum of 2 quarters · filed 2025-02-13 | $3.00B derived: sum of 3 quarters · filed 2025-02-13 | $4.10B derived: sum of 4 quarters · filed 2025-02-13 | |||
| 2023-01-01 | $900.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $1.90B derived: sum of 2 quarters · filed 2025-02-13 | $3.00B derived: sum of 3 quarters · filed 2025-02-13 | $3.90B 10-K · filed 2025-02-13 | $4.30B 10-K · filed 2023-02-16 | |||
| 2022-10-02 | $1.00B 10-Q · filed 2023-10-27 | $2.10B derived: sum of 2 quarters · filed 2023-10-27 | $3.00B 10-Q · filed 2023-10-27 | $3.20B 10-Q · filed 2022-10-27 | $3.80B derived: sum of 4 quarters · filed 2024-02-16 | |||
| 2022-07-03 | $1.10B 10-Q · filed 2023-07-31 | $2.20B 10-Q · filed 2023-07-31 | $2.80B derived: sum of 3 quarters · filed 2024-02-16 | $3.90B derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-04-03 | $1.10B 10-Q · filed 2023-04-28 | $1.70B derived: sum of 2 quarters · filed 2024-02-16 | $2.80B derived: sum of 3 quarters · filed 2024-02-16 | $4.00B derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-01-02 | $600.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $1.70B derived: sum of 2 quarters · filed 2024-02-16 | $2.90B derived: sum of 3 quarters · filed 2024-02-16 | $4.20B 10-K · filed 2024-02-16 | $4.70B 10-K · filed 2022-02-17 | |||
| 2021-10-03 | $1.10B 10-Q · filed 2022-10-27 | $2.30B derived: sum of 2 quarters · filed 2022-10-27 | $3.60B 10-Q · filed 2022-10-27 | $4.80B derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-07-04 | $1.20B 10-Q · filed 2022-07-29 | $2.40B 10-Q · filed 2022-07-29 | $3.70B derived: sum of 3 quarters · filed 2023-02-16 | $4.90B derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-04-04 | $1.20B 10-Q · filed 2022-04-29 | $2.50B derived: sum of 2 quarters · filed 2023-02-16 | $3.70B derived: sum of 3 quarters · filed 2023-02-16 | $4.80B derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-01-03 | $1.30B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $2.50B derived: sum of 2 quarters · filed 2023-02-16 | $3.60B derived: sum of 3 quarters · filed 2023-02-16 | $4.70B 10-K · filed 2023-02-16 | ||||
| 2020-09-27 | $1.20B 10-Q · filed 2021-10-29 | $2.30B derived: sum of 2 quarters · filed 2021-10-29 | $3.40B 10-Q · filed 2021-10-29 | $4.60B derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-06-28 | $1.10B 10-Q · filed 2021-07-29 | $2.20B 10-Q · filed 2021-07-29 | $3.40B derived: sum of 3 quarters · filed 2022-02-17 | $4.50B derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-03-29 | $1.10B 10-Q · filed 2021-04-30 | $2.30B derived: sum of 2 quarters · filed 2022-02-17 | $3.40B derived: sum of 3 quarters · filed 2022-02-17 | $4.50B derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2019-12-29 | $1.20B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $2.30B derived: sum of 2 quarters · filed 2022-02-17 | $3.40B derived: sum of 3 quarters · filed 2022-02-17 | $4.50B 10-K · filed 2022-02-17 | ||||
| 2019-09-29 | $1.10B 10-Q · filed 2020-10-23 | $2.20B derived: sum of 2 quarters · filed 2020-10-23 | $3.30B 10-Q · filed 2020-10-23 | $4.40B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-06-30 | $1.10B 10-Q · filed 2020-07-24 | $2.20B 10-Q · filed 2020-07-24 | $3.30B derived: sum of 3 quarters · filed 2021-02-22 | $4.40B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-03-31 | $1.10B 10-Q · filed 2020-04-29 | $2.20B derived: sum of 2 quarters · filed 2021-02-22 | $3.30B derived: sum of 3 quarters · filed 2021-02-22 | $4.40B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2018-12-30 | $1.10B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $2.20B derived: sum of 2 quarters · filed 2021-02-22 | $3.30B derived: sum of 3 quarters · filed 2021-02-22 | $4.40B 10-K · filed 2021-02-22 | ||||
| 2018-09-30 | $1.10B 10-Q · filed 2019-10-28 | $2.20B derived: sum of 2 quarters · filed 2019-10-28 | $3.30B 10-Q · filed 2019-10-28 | $4.40B derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-07-01 | $1.10B 10-Q · filed 2019-07-29 | $2.20B 10-Q · filed 2019-07-29 | $3.30B derived: sum of 3 quarters · filed 2020-02-18 | $4.40B derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-04-01 | $1.10B 10-Q · filed 2019-05-01 | $2.20B derived: sum of 2 quarters · filed 2020-02-18 | $3.30B derived: sum of 3 quarters · filed 2020-02-18 | $3.80B derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2017-12-31 | $1.10B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $2.20B derived: sum of 2 quarters · filed 2020-02-18 | $2.70B derived: sum of 3 quarters · filed 2020-02-18 | $3.00B 10-K · filed 2020-02-18 | ||||
| 2017-10-01 | $1.10B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $1.60B derived: sum of 2 quarters · filed 2018-10-31 | $1.90B 10-Q · filed 2018-10-31 | $1.89B 10-Q · filed 2017-11-02 | $2.21B derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-07-02 | $500.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $800.00M 10-Q · filed 2018-08-02 | $809.00M 10-Q · filed 2017-08-03 | $1.10B derived: sum of 3 quarters · filed 2019-02-20 | $1.42B derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-04-02 | $300.00M 10-Q · filed 2018-05-01 | $329.00M 10-Q · filed 2017-05-08 | $605.00M derived: sum of 2 quarters · filed 2019-02-20 | $924.00M derived: sum of 3 quarters · filed 2019-02-20 | $1.22B derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-01-01 | $305.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $624.00M derived: sum of 2 quarters · filed 2019-02-20 | $918.00M derived: sum of 3 quarters · filed 2019-02-20 | $1.20B 10-K · filed 2019-02-20 | ||||
| 2016-10-02 | $319.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $613.00M derived: sum of 2 quarters · filed 2017-11-02 | $895.00M 10-Q · filed 2017-11-02 | $1.18B derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-07-03 | $294.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $576.00M 10-Q · filed 2017-08-03 | $864.00M derived: sum of 3 quarters · filed 2018-02-21 | $1.16B derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-04-03 | $282.00M 10-Q · filed 2017-05-08 | $570.00M derived: sum of 2 quarters · filed 2018-02-21 | $863.00M derived: sum of 3 quarters · filed 2018-02-21 | $1.17B derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-01-03 | $288.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $581.00M derived: sum of 2 quarters · filed 2018-02-21 | $888.00M derived: sum of 3 quarters · filed 2018-02-21 | $1.20B 10-K · filed 2018-02-21 | ||||
| 2015-09-27 | $293.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $600.00M derived: sum of 2 quarters · filed 2016-11-04 | $912.00M 10-Q · filed 2016-11-04 | $1.28B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-28 | $307.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $619.00M 10-Q · filed 2016-08-04 | $986.00M derived: sum of 3 quarters · filed 2017-02-27 | $1.32B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-29 | $312.00M 10-Q · filed 2016-05-10 | $679.00M derived: sum of 2 quarters · filed 2017-02-27 | $1.01B derived: sum of 3 quarters · filed 2017-02-27 | $1.36B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-28 | $367.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $702.00M derived: sum of 2 quarters · filed 2017-02-27 | $1.05B derived: sum of 3 quarters · filed 2017-02-27 | $1.40B 10-K · filed 2017-02-27 | $1.40B 10-K · filed 2015-02-24 | |||
| 2014-09-28 | $335.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $682.00M derived: sum of 2 quarters · filed 2015-10-30 | $1.03B 10-Q · filed 2015-10-30 | $1.45B derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2014-06-29 | $347.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $698.00M 10-Q · filed 2015-07-31 | $1.12B derived: sum of 3 quarters · filed 2016-02-24 | $1.45B derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2014-03-30 | $351.00M 10-Q · filed 2015-05-01 | $771.00M derived: sum of 2 quarters · filed 2016-02-24 | $1.10B derived: sum of 3 quarters · filed 2016-02-24 | $1.42B derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2013-12-29 | $420.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $747.00M derived: sum of 2 quarters · filed 2016-02-24 | $1.06B derived: sum of 3 quarters · filed 2016-02-24 | $1.40B 10-K · filed 2016-02-24 | $1.36B 10-K · filed 2014-02-21 | |||
| 2013-09-29 | $327.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $645.00M derived: sum of 2 quarters · filed 2014-10-30 | $980.00M 10-Q · filed 2014-10-30 | $1.26B derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $318.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $653.00M 10-Q · filed 2014-08-01 | $933.00M derived: sum of 3 quarters · filed 2015-02-24 | $1.31B derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $335.00M 10-Q · filed 2014-05-02 | $615.00M derived: sum of 2 quarters · filed 2015-02-24 | $993.00M derived: sum of 3 quarters · filed 2015-02-24 | $1.28B derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-30 | $280.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $658.00M derived: sum of 2 quarters · filed 2015-02-24 | $941.00M derived: sum of 3 quarters · filed 2015-02-24 | $1.15B 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $378.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $661.00M derived: sum of 2 quarters · filed 2013-11-04 | $866.00M 10-Q · filed 2013-11-04 | |||||
| 2012-07-01 | $283.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $488.00M 10-Q · filed 2013-08-01 | ||||||
| 2012-04-01 | $205.00M 10-Q · filed 2013-05-03 | |||||||
| 2012-01-01 | $852.00M 10-K · filed 2014-02-21 | |||||||
| 2011-01-02 | $748.00M 10-K · filed 2013-02-22 | |||||||
| 2010-01-03 | $0.00 10-K · filed 2010-03-01 | |||||||
| 2008-12-28 | $0.00 10-K · filed 2010-03-01 | |||||||
| 2007-12-30 | $678.00M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |